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High healthcare resource utilisation among COPD patients 1735Physical activity;
Healthcare resource
utilisation;
Systemic
inflammationObjectives: To identify factors associated with high utilisation of healthcare resources in a po-
pulation of patients with COPD.
Method: We conducted an observational, cross-sectional, multicentre study with the aim of
identifying the factors associated with high resource utilisation among patients with COPD. So-
ciodemographic and anthropometric characteristics of the study population, as well as data on
health-related quality of life, respiratory symptoms, presence of anxiety and depression, phys-
ical activity and lung function were collected. We examined the relationship between these
variables and high utilisation of healthcare resources, by performing a multivariate analysis
based on a logistic regression model.
Results: 115 patients (64 were high users of healthcare resources, and 51 control patients)
from 13 hospitals were selected. Patients presenting high resource utilisation had worse
FEV1, worse basal SpO2, less distance walked in the 6-minute walk test, and increased dys-
pnoea. They also had a worse BODE index, worse scores in all dimensions of the EURO-QOL
5D and the LCADL scale, and displayed a higher prevalence of depression. Multivariate analysis
yielded a statistically significant association between SpO2, LCADL scores, serum fibrinogen
values and total leukocyte count, and high healthcare resource utilisation.
Conclusions: COPD patients who incur higher healthcare resource utilisation show reduced
physical activity, increased respiratory failure and increased systemic inflammation.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
COPD is currently the fourth leading cause of mortality
throughout the world and it is estimated to be the third
cause of death by the year 2020. Given its high prevalence
and chronicity, COPD is a social burden and places
substantial healthcare costs on public health systems.1e3
This economic burden increases with disease progression,
age and frequent exacerbations, which might represent up
to 70% of all health expenditure and have an increasingly
demonstrated relationship with reduced survival.3
When it comes to assessing COPD severity, besides the
predictive ability of FEV1, there are various approaches
that are used to improve prediction of mortality in COPD
patients. In fact, the multidimensional BODE index (body
mass index, obstruction, dyspnoea and exercise capacity)
appears to be a better predictor of mortality due to
respiratory causes4 than FEV1. Assessment and scoring of
dyspnoea and health status by means of specific question-
naires also provide useful information on the impact of
exacerbations and the efficacy of pharmacological and non-
pharmacological therapy such as pulmonary rehabilitation.5
There is growing evidence of the systemic effects of COPD,
namely systemic inflammation, skeletal muscle dysfunc-
tion, hormone alterations, cardiovascular effects and
osteoskeletal effects.6,7 Malnourishment, sociocultural and
economic background, and psychological disorders, such as
anxiety and depression, are other factors that also influ-
ence the health status of COPD patients and may increase
the risk for hospitalisation due to exacerbations.8,9
In daily clinical practice, it is not uncommon to find
COPD patients who, regardless of COPD severity, repeat-
edly require healthcare assistance; not only in terms of
hospitalisations but also scheduled and non-scheduled
office visits and emergency visits. There are a number of
previous studies that have tried to characterise the afore-
mentioned group of patients with high healthcare resource
utilisation in order to identify possible ways of action tomanage such individuals.10e12 Notwithstanding, the
outcomes yielded differ across the studies. In this study, we
collected data from a series of tests performed in a group of
mild to severe COPD patients monitored by the respiratory
services of Spanish public hospitals, in order to identify the
clinical and functional characteristics associated with the
high utilisation of healthcare services.Method
The present study was a multicentre, observational study
aimed at identifying the characteristics of COPD patients
associated with high utilisation of healthcare resources.
The characteristics of this study have been described in
a previous investigation examining hospital admissions for
exacerbations.13 In the current study we defined the
concept of high healthcare resource utilisation and ana-
lysed the determinants associated with this type of
patients.
The inclusion criteria were patients aged >40 yrs. with
physician-diagnosed COPD according to the GOLD criteria
(post-bronchodilator FEV1/FVC < 0.7), were clinically
stable (no exacerbations in the last four weeks), and were
current or former smokers with a smoking history of 10
pack-yrs. High resource utilisation was defined as those
patients who, in the year prior to their participation in the
study, had at least: a) 1 hospital admission for COPD
exacerbation, b) 2 or more visits to emergency units due to
an exacerbation, or c) 2 or more non-scheduled COPD-
related visits to outpatient clinics. The remaining patients
were defined as patients with low resource utilisation or
control group.
Data were obtained by means of a clinical interview
including demographic characteristics and socioeconomic
and education background. The number of COPD-related
visits for medical assistance in the year prior to the study
was also collected. Moreover, data obtained from routine
1736 C. Garcı´a-Polo et al.tests were examined, namely haemogram, biochemical
tests for ferritin levels, fibrinogen, total protein, alfa-1
antitrypsin plasma levels and arterial blood gas measure-
ment taken of room air. Pulmonary function testing was
also performed in clinically stable patients, by means of
spirometry and a post-bronchodilator test. A 6-min walking
test was carried out, following the SEPAR (Spanish Society
of Pneumology and Thoracic Surgery) guidelines.14 The
BODE index was estimated as described elsewhere.4 The
total BODE score may range from 0 to 10 points; the higher
the BODE score, the higher the risk of death.
Comorbidity was assessed with the Charlson Comorbidity
Index.15 Whenever possible, an electrocardiogram (ECG)
and transthoracic echocardiography were performed to test
heart function.
Health-related quality of life (HRQ0L) was measured
with the European quality of life (EuroQoL) five-dimension
questionnaire (EQ-5D).16 The EQ-5D is a standardised
generic instrument which is applied in a variety of diseases
and provides useful information through a self-classifier/
descriptive system of the respondent’s own health and
a single summary index value representing his/her overall
health state. The questionnaire consists of five questions
that are converted into a single summary index (the VAS
scores range from 0 to 100, and scores close to 100 reflect
better health state), and a visual analogue scale (VAS).
Dyspnoea was measured by the Medical Research Council
(MRC) scale,17 whereas physical activity was assessed using
the validated Spanish version19 of the London Chest Activity
of Daily Living (LCADL) Scale.18 The LCADL scale is a self-
administered 15-item questionnaire consisting of 4
domains or subscales. For each activity the patient reports
a score on a rating scale ranging from 0 to 5 (0 Z ‘I
wouldn’t do it anyway’, and 5 Z ‘someone else does this
for me (or helps)’). The score of each of the 4 domains and
the total LCADL score, the latter ranging from 0 (reflecting
low disability) to 75 (maximal disability), are then calcu-
lated. Patients were also asked to complete the Hospital
Anxiety and Depression Scale (HADS),20 a validated tool
used to assess symptoms and identify cases of anxiety
disorders and depression in patients with chronic disease.
This measure comprises 7 depression items (Depression sub-
scale or HAD-D) and 7 anxiety items (Anxiety sub-scale or
HAD-A). Scores on each sub-scale can be interpreted in
ranges from 0 to 21. A score from 0 to 7 indicates no
depression or anxiety, a score from 8 to 10 is suggestive of
the presence of the respective mood disorder, and a score
of 11 or higher probable presence of the mood disorder.
The study protocol was approved by the Ethics
Committee of the University Hospital Puerta del Mar (Ca´diz,
Spain), and all study participants provided written informed
consent.Statistical analysis
The Student’s t test was used for comparison of normally
distributed continuous variables whereas the Man-
neWhitney U test was used for not normally distributed
continuous variables. Chi-square test was applied for
comparison of categorical variables and the corresponding
p-value obtained is presented in the study.With regard to the assessment of physical activity,
a linear regression model, which included the LCADL score
as a dependent variable and the distance walked in the
6MWT as the independent variable, together with data
adjustment and estimation of the goodness of fit of the
model were carried out.
A multivariate analysis based on a logistic regression
model was carried out by adjusting the variable under
study, namely high resource utilisation, for all the variables
showing significant differences across the two study groups
in the bivariate analysis. A predictive model for high uti-
lisation of healthcare resources was constructed with the
regression analysis variables associated with elevated uti-
lisation of healthcare resources. Therefore, the area under
the curve (AUC) and its confidence interval value (95%)
were calculated. A p-value less than 0.05 was considered to
be statistically significant. The data analysis was performed
using the SPSS v18 statistical package.Results
A total of 137 patients were recruited and 115 completed
the necessary data to be included in the study; of these 64
were high users of healthcare resources and 51 control
participants. The mean age of the study population (DE)
was 66.9  8.7. 93% of the study population were male,
presented a smoking history of 51.5  27 pack-years,
showed a mean post-bronchodilator FEV1 (of the pre-
dicted value, %p) of 43.7  15%, and had a mean body mass
index (BMI) of 26.8  5.6. The Charlson Comorbidity Index
score was 4.4 and the mean BODE index was 3.7. Anthro-
pometric and sociodemographic characteristics, pulmonary
and heart function tests, treatment received and
biochemical parameters of the study population are dis-
played in Table 1.
Patients with high utilisation of healthcare resources
showed a higher MRC dyspnoea degree (2.03  0.9 versus
1.4  1; p Z 0.001), lower SpO2 (89.7%  12.2 versus
94.1%  3.4; p Z 0.007) and greater airflow obstruction
(FEV139.6%  17.6 versus 46.9%  16.5; p Z 0.024).
Moreover, in the case of patients presenting high utilisation
of healthcare resources, the distance walked in the 6MWT
was shorter (357.5 m  128.4 versus 425.6 m  125.8;
p Z 0.006), and the total BODE index score was higher
(4.3  2.3 versus 3.1  2.1; p Z 0.024).
With respect to the Charlson Comorbidity Index, there
were no differences across the study groups, whereas the
echocardiographic study performed in a subset of 73 patients
(42 of these patients were high users of resources) (Table 2)
yielded differences across different parameters. The differ-
ences, however, were only significant for the left ventricular
ejection fraction, which was lower in the group of high
resource utilisation (59.5%  9.8 versus 64.4%  9.2;
pZ 0.033). Blood inflammatoryparameterswere significantly
higher in patients with high utilisation of resources: with
fibrinogen values of 408.3 mg/dL  207 versus 306.4  192;
pZ 0.007 and leukocyte counts of 8.870 cells/mm3  2.930
versus 7.320 cells/mm3  2.036; pZ 0.001 (Table 2).
With regard to the health-related quality of life, physical
activity, and anxiety/depression questionnaires, significant
differences were observed across both study groups
Table 1 Characteristics of the study population.
Global (n Z 115) High resource
utilisation
(n Z 64, 55.6%)
Control group
(n Z 51, 44.4%)
p-Value
Age (years) 66.9  8.7 66.6  9.4 67.2  8.0 0.74
Sex (% male) 107 (93.0%) 60 (93.8%) 47 (92.2%) 0.51
Marital status 0.86
Single 11 (9.6%) 7 (10.9%) 4 (7.8%)
Couples 77 (67.0%) 42 (65.6%) 35 (68.6%)
With family 27 (23.5%) 15 (23.4%) 12 (23.5%)
Education background 0.17
W/o education 31 (27.0%) 19 (29.7%) 12 (23.5%)
Primary 49 (42.6%) 30 (46.9%) 19 (36.3%)
Secondary 21 (18.3%) 10 (15.6%) 11 (21.6%)
University 13 (11.5%) 4 (6.3%) 9 (17.6%)
Missing 1 (0.6%) 1 (1.5%) 0
Current smokers (%) 28 (24.3%) 15 (23.4%) 13 (25.5%) 0.95
Former smokers (%) 87 (75.7%) 49 (76.6%) 38 (74.5%)
Pack-years 51.5  27.6 51.0  31.1 52.0  22.3 0.85
BMI (kg/m2) 26.8  5.8 26.3  6.0 27.4  5.5 0.34
Charlson Index 4.39  2.1 4.19  1.9 4.65  2.4 0.15
Dyspnoea (MRC) 1.75  1.04 2.03  0.9 1.39  1.0 0.001
Spirometry
FEV1 (%) 43.7  15.1 39.6  17.6 46.9  16.5 0.024
FEV1 mL 1.205  511 1.058  509 1.310  520 0.010
FVC (%) 69.5  21.5 64.5  26.5 74.0  18.81 0.026
FVC mL 2.560  932 2.344  1144 2.771  887 0.032
FEV1/FVC 46.4  12.8 45.5  14.1 47.1  11.4 0.51
Six-minute walk test, m 386  131 357  128 425  125 0.006
BODE index 3.87  2.30 4.31  2.34 3.13  2.14 0.024
ABG, room air
PaO2, mm Hg 67.4  12.1 64.4  11.5 71.8  11.8 0.003
PaCO2, mm Hg 44.3  8.7 45.2  8.19 43.0  9.5 0.24
pH 7.42  6.5 7.42  5.12 7.41  8.34 0.50
SpO2 % 92.6  4.1 89.7  2.23 94.1  3.45 0.007
Treatment for COPD
SABA % 93 (80.9%) 57 (89.1%) 36 (70.6%) 0.029
LABA % 103 (89.6%) 58 (90.6%) 45 (88.2%) 0.53
Ipratropium % 9 (7.8%) 5 (7.8%) 4 (7.8%) 0.20
Tiotropium% 99 (86.1%) 57 (89.1%) 42 (82.4%) 0.39
Theophyllines % 21 (18.3%) 12 (18.8%) 9 (17.6%) 0.16
Inhaled corticosteroids % 104 (90.4%) 59 (92.2%) 45 (88.2%) 0.41
Mucolytics % 45 (39.1%) 29 (45.3%) 16 (31.4%) 0.14
LTOT % 25 (21.7%) 21 (32.8%) 4 (7.8%) 0.003
Rehabilitation % 14 (12.2%) 8 (12.5%) 6 (11.8%) 0.27
Antinfluenza vaccination % 83 (72.2%) 48(75%) 35 (68.6%) 0.43
Antipneumococcal
vaccination %
40 (34.8%) 18 (28.1%) 22 (43.1%) 0.05
Bold values signify the comparisons with statistically significant p values.
BMI: body mass index. PaO2: oxygen partial pressure. PaCO2: carbon dioxide, partial pressure. SpO2: haemoglobin, oxygen saturation.
ABG: arterial blood gases. SABA: short acting beta agonists. LABA: long acting beta agonists. LTOT: long term oxygen therapy.
High healthcare resource utilisation among COPD patients 1737(Table 3). Patients with high resource utilisation showed
significantly worse EQ-5D scores, in terms of total EQ-5D
score (0.64  0.35 versus 0.82  0.22; p Z 0.002), VAS
and each of its individual domains. Regarding the LCDAL wefound significant differences in the total LCDAL score
(47.1  12.4 versus 39  14.1; p Z 0.002) as well as in the
self-care and physical domains. The total LCADL score dis-
played a moderate and statistically significant correlation
Table 2 Biochemical and echocardiographic parameters.
Biochemical Global (n Z 115) High resource
utilisation (n Z 64)
Control group (n Z 51) p-Value
Haemoglobin (gr/dL) 14.2  2.7 13.9  2.9 14.5  2.5 0.25
Leukocyte count (103/mL) 8.190  2.68 8.870  2.93 7.320  2.03 0.001
Fibrinogen (mg/dL) 366.8  204 408.2  207.16 306.1  192.4 0.007
Proteins (mg/dL) 7.18  0.86 7.09  0.92 7.29  0.78 0.053
Alfa1- antitrypsin (mg/dL) 125.3  60.5 118.9  62.65 133.3  57.36 0.20
Ferritin (mg/dL) 152  110 163  129 143  92 0.62
C-reactive protein (mg/dl) 3.16  5.01 3.27  5.33 3.04  6.01 0.86
Echocardiography Global (n Z 68) High resource
utilisation (n Z 42)
Control group (n Z 26) p-Value
Right chamber enlargement % 11 (16.1%) 8 (19%) 3 (9.1%) 0.076
LVEF, % 61.8  9.7 59.5  9.8 64.4  9.2 0.033
Tricuspid regurgitation, % 31 (45.6%) 21 (50%) 10 (32.2%) 0.095
Diastolic dysfunction, % 29 (42.6%) 20 (47.6%) 9 (29%) 0.10
Bold values signify the comparisons with statistically significant p values.
LVEF: left ventricle ejection fraction.
1738 C. Garcı´a-Polo et al.with the distance walked in the 6MWT, as suggested in the
linear regression model (r Z 0.24, p < 0.01) (Fig. 1).
Patients with high utilisation of resources presented worse
HAD-A and HAD-D scores, and showed significantly higher
rates of probable presence of depression (31.2% versus
16.6%; p Z 0.046) as shown in Fig. 2.
The multivariate analysis carried out applying logistic
regression in significant variables showed a worse SpO2,
worse LCADL score, higher levels of peripheral blood
leukocytes and high levels of fibrinogen, with an AUC ofTable 3 Health-related quality of life (HRQoL), physical activit
Global (n Z 115) Hi
ut
Euro-QOL-5D
EQ-5D index 0.72  0.31 0.
EQ-5D VAS score 58.6  20.1 56
EQ-5D VAS index 0.70  0.25 0.
London Chest Activity Daily Living (LCADL) Scale
Self-care 10.5  3.0 11
Domestic 17.8  10.4 19
Physical 6.8  1.8 7.
Leisure 7.7  4.4 7.
Global 43.5  13.8 47
How much does your shortness of breath affect your life?
Much 33 (28.7%) 26
A little 67 (58.2%) 35
Nothing 15 (13.1%) 3
Hospital Anxiety and Depression Scale (HADS)
Anxiety score 5.1  4.0 5.
Depression score 5.0  3.9 6
Anxiety likely/definitively (%) 13 (11.3%) 10
Depression likely/definitively (%) 28 (24.3%) 20
EQ-5D index: European quality of life (EuroQOL) five-dimension total
Bold values signify the comparisons with statistically significant p val
EQ-5D VAS score: European quality of life visual analogue scale.0.829 (Table 4) to be independent determinants of high
utilisation of healthcare resources. These determinants
were found to be better than the BODE index for discrimi-
nating patients with high resource utilisation (Fig. 3).Discussion
The results obtained in this study show that patients pre-
senting high healthcare resource utilisation arey, and anxiety and depression scales.
gh resource
ilisation (n Z 64)
Control group (n Z 51) p-Value
64  0.35 0.82  0.22 0.002
 19 61.9  21.2 0.12
64  0.27 0.78  0.20 0.002
.4  3.4 9.3  1.9 0.000
.2  10.4 16.2  10.4 0.130
3  1.8 6.0  1.5 0.000
5  2.0 7.9  6.3 0.623
.1  12.4 39  14.1 0.002
(40.6%) 7 (14.0%) 0.001
(52.2%) 32 (64.0%)
(4.7%) 12 (22.0%)
8  4 4.1  4 0.021
 4.1 3.8  2.6 0.003
(15.62%) 3 (6.25%) 0.216
(31.25%) 8 (16.6%) 0.046
score.
ues.
6MWT
6004002000
80
70
60
50
40
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20
r=0,24 (p<0,01)
LCADL
Figure 1 Relationship between the LCADL score and distance
walked in the 6MW.
Table 4 Multivariate analysis. Determinants of high
resource utilisation.
Parameter OR CI 95%
BODE index 0.832 0.625e1.130
SpO2 0.869 0.760e0.994
LCADL 1.046 1.001e1.093
EQ-5D 0.548 0.060e4.999
HAD-anxiety 0.934 0.792e1.101
HAD-depression 1.111 0.926e1.334
Leukocyte count (103/mL) 1.295 1.032e1.625
Fibrinogen (mg/dL) 1.005 1.002e1.008
Sensibility 67.95%
Specifity 81.78%
Positive predictive value (PPV) 82.73%
Negative predictive value (NPV) 65.66%
ROC curve, AUC 0.829
Bold values signify the comparisons with statistically significant
p values.
SpO2: Haemoglobin, oxygen saturation; LCADL: London Chest
Activities of Daily Living Scale; EQ-5D: European quality of life
(EuroQOL) five-dimension scale; HADS: Hospital Anxiety and
Depression Scale; ROC curve: receiver operating characteristics
curve; AUC: area under the curve.
High healthcare resource utilisation among COPD patients 1739characterised by lower levels of physical activity, as
measured by the LCADL scale, worse SpO2 and evidence of
increased systemic inflammation, as suggested by increased
fibrinogen values and greater leukocyte counts in periph-
eral blood. These three factors allow more effective iden-
tification of the patients with a high utilisation of
healthcare resources than the BODE index, yielding an AUC
of 0.829. Although validation by a prospective cohort study
should be performed, the aforementioned factors may be
a useful tool for identifying this subgroup of patients that
place a high economic burden on healthcare systems and
they can be applied at all levels of healthcare.
These results confirm the impact that reduced physical
activity has on COPD patients.21 It is widely known that
lower levels and intensity of daily physical activity can be
observed in early stages of COPD.22 Limited physical
activity is associated with a poorer health-related quality of
life,23,24 a greater risk of hospital admissions,25 and even
higher mortality rates.25,26 Likewise, in our study theFigure 2 Anxiety and depression percentages across the
study groups.patients with high resource utilisation also displayed
significantly limited physical activity, as measured by the
LCADL questionnaire and the 6MWT. In the multivariate
analysis, only the LCADL score had a significant association
with high use of healthcare resources. This finding may
suggest that the impact of COPD on physical activity does
not only become apparent in reduced physical capacity but
also in other intervening psychosocial factors that increase
disease impact and can be objectively measured with
a standardised questionnaire.18,19,27 In this respect, there
was a significant, albeit weak, correlation between the
6MWT and the LCADL scale. The results obtained are of
great interest, since performing the 6MWT during primary
care consultations is difficult to achieve. However,Figure 3 ROC curves for the prediction of high resource
utilisation for BODE index and the proposed model (SpO2,
leukocyte count, fibrinogen, LCADL).
1740 C. Garcı´a-Polo et al.administering daily physical activity questionnaires such as
the LCADL, which are brief, self-completed scales, can
provide useful information and are even of better predic-
tive value in relation to the prognosis of the patient. The
design of our study did not allow determination as to
whether the changes in daily physical activity translate into
a reduction in the utilisation of healthcare resources,
although some studies have suggested this possibility. In
fact, Esteban et al.23 demonstrated that an increase in the
level of physical activity is associated with a significant
improvement in health status. Surprisingly, despite such
evidence, there were no differences regarding the uti-
lisation of a rehabilitation program or in pharmacological
therapy across the two groups of patients.
The relationship between physical activity and quality of
life was also reflected in our population. Patients with
COPD and high utilisation of resources presented worse EQ-
5D scores. A similar relationship was described between
greater worsening of quality of life and increased utilisation
of healthcare resources in a previous caseecontrol study
using the St George’s Respiratory Questionnaire.11 This
association may be due to the relationship between acute
exacerbations and hospital admissions, which is charac-
teristic among patients with high utilisation of healthcare
resources, and diminished physical activity28 and quality of
life.29,30
There was also a clear trend towards higher levels of
depression and anxiety among patients with high utilisation
of resources. These patients showed a higher HAD score and
a higher percentage of patients showed a probable pres-
ence depression. Depression is a common comorbidity in
COPD patients,31 and comorbid depression has been proven
to be a predictor of acute exacerbations, hospital admis-
sions32 and greater mortality.33 Detection of depression
might enable pharmacological and psychological interven-
tions, which might therefore potentially reduce high
healthcare resource use. Previous studies highlight that
adequate pulmonary rehabilitation can reduce anxiety and
depression in COPD patients, and thus lead to improved
quality of life and physical activity.34e36 Anxiety, which was
more common in the study patients with high utilisation of
resources, is also associated with a higher risk of acute
exacerbations and hospitalisations among COPD
patients.8,36,37 Despite the significant differences in the
prevalence of anxiety and depression across the study
groups in our study, these variables were not statistically
significant in the multivariate analysis possibly due to an
association with the LCADL score.
Interestingly, no significant differences in pharmaco-
logical treatment were observed between groups. Poor
compliance with treatment might play a role in increasing
healthcare resource utilisation, but the design of the study
did not allow analysis of this factor.
Another observation is that the group of patients with
high resource utilisation displayed greater systemic
inflammation, as measured by leukocytes and fibrinogen,
with respect to the control group. This result is similar to
the findings of recent studies, in which exacerbations are
associated with high fibrinogen levels, and are predictors of
COPD-related hospital admissions and mortality.38e40
Moreover, the hypoxia found among high users of
resources is also associated with systemic inflammation,41as shown in our study. The relationship between greater
systemic inflammation and a lower level of physical activity
has been observed among other COPD patients.42,43 These
findings suggest that patients with a high utilisation of
healthcare resources and frequent acute exacerbations
have reduced physical activity, elevated systemic inflam-
mation, poor quality of life and higher rates of anxiety and
depression, all of which lead to a higher risk of acute
exacerbations, hence a vicious circle which is difficult to
break.
It is worth pointing out that even though the sample
population that underwent the echocardiographic test
was small, patients with high utilisation of resources
displayed a significantly reduced left ventricle ejection
fraction and a clear trend towards greater pulmonary
hypertension. These findings also support those of recent
investigations which highlight the importance of cardio-
vascular comorbidity as a predictor of exacerbations,44
and greater cardiac comorbidity in patients requiring
frequent hospital care.11 Further research into the rela-
tionship between cardiac comorbidity and utilisation of
health resources in a larger sample of patients with COPD
is required.
Given its cross-sectional nature, this study presents
some limitations, which do not allow causal relations to be
established. Therefore, we believe that our outcomes
should be confirmed by further prospective long-term
follow-up studies. Likewise, the impossibility of perform-
ing echocardiography in the whole study population poses
some limitation to our conclusions on cardiac comorbidity
among such patients. However, the present study has
important strengths, such as its multicentre design and the
inclusion of the data collected that are easy to apply in
everyday clinical practice and enable its implementation in
the routine management of COPD patients. The findings
presented in the study suggest the presence of a group of
COPD patients who place a high economic burden ton
health systems and present a series of distinctive charac-
teristics. The next step would involve the study of how
management of the factors linked to high utilisation of
health resources can improve the prognosis of COPD
patients.
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